THRIVENCT06395506
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 11 versions: 10 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 37 words Show 7 more changesShow less
- Enrollment closed, study ongoing
- Final enrollment: 39 participants (planned 60)
- Primary completion date changed from estimate of May 31, 2028 to Oct 21, 2026
- Study completion moved earlier from May 31, 2028 to Jul 31, 2027
- Secondary endpoints: 3 to 2
- Site details revised
- Publications: details revised at 1 of 1 entry
- Minor Start date changed from estimate of Nov 1, 2024 to Oct 29, 2024v9
- Minor Start date: Oct 31, 2024 to Nov 1, 2024
- Site contact updated
- Notable Start date: Sep 30, 2024 to Oct 31, 2024
- Site contact updated
- Notable Start date: Aug 30, 2024 to Sep 30, 2024v6
Show 4 earlier versionsHide 4 earlier versions
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date: Jul 30, 2024 to Aug 30, 2024
- Site details revised
- Notable Start date: Jun 30, 2024 to Jul 30, 2024v4
- Notable Start date: May 31, 2024 to Jun 30, 2024v3
- Study Identification, Study Statusv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (2)
Arms and interventions
Women who have never been diagnosed with cancer.
Those randomized to receive creatine (experimental group) will be initially dosed at 20 g/day for 7 days to boost availability of creatine systemically. Thereafter, the dose will be reduced to 5 g/day for maintenance through the duration of the 12-week protocol. Participants will engage in three center-based exercise sessions each week for 12 weeks; each session lasting roughly 1-hour. Participants will be given a fitbit (electronic watch that measures steps or heart rate) as well to track heart rate and monitor activity throughout the study.
Participants will engage in three center-based exercise sessions each week for 12 weeks; each session lasting roughly 1-hour. Participants will be given a Fitbit (electronic watch that measures steps or heart rate) as well to track heart rate and monitor activity throughout the study.
Dietary supplements: Creatine
Sites
1 site in 1 country
- The University of Texas Medical Branch, GalvestonGalveston, Texas, United States